Vestmark Advisory Solutions Inc. Buys Shares of 4,067 The Cigna Group (NYSE:CI)

Vestmark Advisory Solutions Inc. purchased a new position in shares of The Cigna Group (NYSE:CI - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 4,067 shares of the health services provider's stock, valued at approximately $1,218,000.

A number of other institutional investors and hedge funds have also modified their holdings of CI. Bogart Wealth LLC increased its stake in The Cigna Group by 104.5% in the third quarter. Bogart Wealth LLC now owns 90 shares of the health services provider's stock valued at $26,000 after purchasing an additional 46 shares in the last quarter. OFI Invest Asset Management acquired a new position in The Cigna Group during the third quarter worth $26,000. Fortitude Family Office LLC acquired a new stake in The Cigna Group in the fourth quarter valued at $29,000. VisionPoint Advisory Group LLC lifted its stake in The Cigna Group by 112.2% in the third quarter. VisionPoint Advisory Group LLC now owns 104 shares of the health services provider's stock valued at $30,000 after acquiring an additional 55 shares during the last quarter. Finally, Pacifica Partners Inc. lifted its stake in The Cigna Group by 73.2% in the fourth quarter. Pacifica Partners Inc. now owns 142 shares of the health services provider's stock valued at $43,000 after acquiring an additional 60 shares during the last quarter. 86.99% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages have commented on CI. Deutsche Bank Aktiengesellschaft upgraded shares of The Cigna Group from a "hold" rating to a "buy" rating and increased their price target for the company from $355.00 to $370.00 in a research note on Thursday, February 1st. Mizuho raised their target price on shares of The Cigna Group from $360.00 to $370.00 and gave the stock a "buy" rating in a research note on Monday, February 5th. Wells Fargo & Company raised their target price on shares of The Cigna Group from $334.00 to $348.00 and gave the stock an "equal weight" rating in a research note on Tuesday, February 6th. Morgan Stanley restated an "overweight" rating and set a $392.00 target price (up previously from $382.00) on shares of The Cigna Group in a research note on Monday, March 4th. Finally, Cantor Fitzgerald raised their price target on shares of The Cigna Group from $384.00 to $400.00 and gave the stock an "overweight" rating in a research report on Friday. Two research analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus price target of $366.14.

The Cigna Group Trading Up 0.3 %

Shares of NYSE:CI traded up $0.91 during trading on Monday, reaching $342.41. The stock had a trading volume of 1,320,046 shares, compared to its average volume of 1,590,367. The firm's fifty day moving average is $350.77 and its 200 day moving average is $319.93. The company has a debt-to-equity ratio of 0.75, a quick ratio of 0.71 and a current ratio of 0.71. The Cigna Group has a 52 week low of $240.50 and a 52 week high of $365.71. The stock has a market cap of $97.27 billion, a price-to-earnings ratio of 28.11, a P/E/G ratio of 1.04 and a beta of 0.57.

The Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings data on Thursday, May 2nd. The health services provider reported $6.47 earnings per share for the quarter, topping the consensus estimate of $6.17 by $0.30. The Cigna Group had a net margin of 1.76% and a return on equity of 17.24%. The firm had revenue of $57.25 billion for the quarter, compared to the consensus estimate of $56.59 billion. During the same quarter in the prior year, the company posted $5.41 earnings per share. The business's revenue was up 23.2% on a year-over-year basis. As a group, equities analysts forecast that The Cigna Group will post 28.45 EPS for the current fiscal year.

The Cigna Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, June 20th. Stockholders of record on Tuesday, June 4th will be issued a $1.40 dividend. The ex-dividend date is Tuesday, June 4th. This represents a $5.60 annualized dividend and a dividend yield of 1.64%. The Cigna Group's dividend payout ratio is currently 45.98%.

Insider Activity

In other news, SVP Hoeltzel Mary T. Agoglia sold 4,867 shares of the stock in a transaction dated Wednesday, February 7th. The shares were sold at an average price of $330.48, for a total value of $1,608,446.16. Following the completion of the sale, the senior vice president now owns 2,102 shares in the company, valued at $694,668.96. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, SVP Hoeltzel Mary T. Agoglia sold 4,867 shares of the stock in a transaction dated Wednesday, February 7th. The shares were sold at an average price of $330.48, for a total value of $1,608,446.16. Following the completion of the sale, the senior vice president now owns 2,102 shares in the company, valued at $694,668.96. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Eric P. Palmer sold 1,017 shares of the stock in a transaction dated Friday, February 9th. The shares were sold at an average price of $335.26, for a total transaction of $340,959.42. Following the transaction, the insider now owns 45,564 shares of the company's stock, valued at approximately $15,275,786.64. The disclosure for this sale can be found here. Insiders sold a total of 114,144 shares of company stock worth $39,296,330 over the last quarter. Insiders own 0.70% of the company's stock.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.